{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:28:43Z","timestamp":1791599323461,"version":"4.3.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["20FC1053"],"award-info":[{"award-number":["20FC1053"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K14953"],"award-info":[{"award-number":["JP23K14953"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"DOI":"10.1186\/s12969-025-01059-6","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T01:54:45Z","timestamp":1737597285000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Monocyte STAT1 phosphorylation and treatment response of JAK inhibitors in chronic nonbacterial osteomyelitis"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0167-3322","authenticated-orcid":false,"given":"Motoshi","family":"Sonoda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keishiro","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungyeon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichi","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaro","family":"Yada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhide","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Kido-Nakahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Kinjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Ishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouichi","family":"Ohga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"key":"1059_CR1","doi-asserted-by":"crossref","unstructured":"Zhao DYD, McCann L, Hahn G, Hedrich CM. Chronic nonbacterial osteomyelitis (CNO) and chronic recurrent multifocal osteomyelitis (CRMO). J Transl Autoimmun. 2021;4:100095.","DOI":"10.1016\/j.jtauto.2021.100095"},{"key":"1059_CR2","doi-asserted-by":"crossref","unstructured":"Li SWS, Roberts E, Hedrich C. Treatment and monitoring of SAPHO syndrome: a systematic review. RMD Open. 2023;9(4):e003688.","DOI":"10.1136\/rmdopen-2023-003688"},{"issue":"3","key":"1059_CR3","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jbspin.2015.07.010","volume":"83","author":"Q Xiong","year":"2016","unstructured":"Xiong Q, Zhang LH, Ge W, Tang PF. The roles of interferons in osteoclasts and osteoclastogenesis. Joint Bone Spine. 2016;83(3):276\u201381.","journal-title":"Joint Bone Spine"},{"issue":"1","key":"1059_CR4","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jaci.2021.05.018","volume":"149","author":"M Tsumura","year":"2022","unstructured":"Tsumura M, Miki M, Mizoguchi Y, Hirata O, Nishimura S, Tamaura M, et al. Enhanced osteoclastogenesis in patients with MSMD due to impaired response to IFN-\u03b3. J Allergy Clin Immunol. 2022;149(1):252\u201361.","journal-title":"J Allergy Clin Immunol"},{"key":"1059_CR5","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","volume":"127","author":"J Toubiana","year":"2016","unstructured":"Toubiana J, Okada S, Hiller J, Oleastro M, Gomez M, Becerra J, et al. Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype. Blood. 2016;127:3154\u201364.","journal-title":"Blood"},{"key":"1059_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jaci.2023.10.018","volume":"153","author":"M Fischer","year":"2024","unstructured":"Fischer M, Olbrich P, Hadjadj J, Aumann V, Bakhtiar S, Barlogis V, et al. JAK inhibitor treatment for inborn errors of JAK\/STAT signaling: An ESID\/EBMT-IEWP retrospective study. J Allergy Clin Immunol. 2024;153:275\u201386.","journal-title":"J Allergy Clin Immunol"},{"key":"1059_CR7","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/acr.23462","volume":"70","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Wu E, Oliver M, Cooper A, Basiaga M, Vora S, et al. Consensus treatment plans for chronic nonbacterial osteomyelitis refractory to nonsteroidal antiinflammatory drugs and\/or with active spinal lesions. Arthritis Care Res (Hoboken). 2018;70:1228\u201337.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1059_CR8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1146\/annurev-med-051113-024537","volume":"66","author":"JJ O'Shea","year":"2015","unstructured":"O\u2019Shea JJ, Schwartz DM, Villarino AV, Gadina M, McInnes IB, Laurence A. The JAK-STAT pathway: impact on human disease and therapeutic intervention. Annu Rev Med. 2015;66:311\u201328.","journal-title":"Annu Rev Med"},{"issue":"2","key":"1059_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1136\/ard-2023-223850","volume":"83","author":"M Bonelli","year":"2024","unstructured":"Bonelli M, Kerschbaumer A, Kastrati K, Ghoreschi K, Gadina M, Heinz LX, et al. Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story. Ann Rheum Dis. 2024;83(2):139\u201360.","journal-title":"Ann Rheum Dis"},{"issue":"25","key":"1059_CR10","doi-asserted-by":"publisher","first-page":"e11149","DOI":"10.1097\/MD.0000000000011149","volume":"97","author":"Q Yang","year":"2018","unstructured":"Yang Q, Zhao YM, Li C, Luo YP, Hao WX, Zhang W. Case report: successful treatment of refractory SAPHO syndrome with the JAK inhibitor tofacitinib. Medicine. 2018;97(25):e11149.","journal-title":"Medicine"},{"issue":"1","key":"1059_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1001\/jamadermatol.2020.3095","volume":"157","author":"C Li","year":"2021","unstructured":"Li C, Li ZH, Cao YH, Li L, Li F, Li YT, et al. Tofacitinib for the treatment of nail lesions and palmoplantar pustulosis in synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome. JAMA Dermatol. 2021;157(1):74\u20138.","journal-title":"JAMA Dermatol"},{"key":"1059_CR12","doi-asserted-by":"publisher","first-page":"911922","DOI":"10.3389\/fimmu.2022.911922","volume":"13","author":"FF Yuan","year":"2022","unstructured":"Yuan FF, Luo J, Yang Q. SAPHO syndrome complicated by ankylosing spondylitis successfully treated with tofacitinib: a case report. Front Immunol. 2022;13:911922.","journal-title":"Front Immunol"},{"issue":"11","key":"1059_CR13","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1007\/s10067-022-06304-x","volume":"41","author":"H Xu","year":"2022","unstructured":"Xu H, Chen NG, Li C. Frontal bone involvement in SAPHO syndrome. Clin Rheumatol. 2022;41(11):3585\u20137.","journal-title":"Clin Rheumatol"},{"issue":"8","key":"1059_CR14","first-page":"e66169","volume":"16","author":"M Alhayali","year":"2024","unstructured":"Alhayali M. Successful treatment of refractory Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) syndrome with tofacitinib: a case report. Cureus. 2024;16(8):e66169.","journal-title":"Cureus"},{"issue":"4","key":"1059_CR15","doi-asserted-by":"publisher","first-page":"e01342","DOI":"10.14309\/crj.0000000000001342","volume":"11","author":"B Kim","year":"2024","unstructured":"Kim B, Thiemann A, Dietz B, Beck K. Refractory ulcerative colitis with associated synovitis, acne, pustulosis, hyperostosis, osteitis syndrome successfully treated with tofacitinib. ACG Case Rep J. 2024;11(4):e01342.","journal-title":"ACG Case Rep J"},{"key":"1059_CR16","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2147\/CCID.S446468","volume":"17","author":"J Yang","year":"2024","unstructured":"Yang J, Yuan C, Zhou S, Teng Z, Li M. Successful treatment of refractory Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) syndrome with baricitinib, a janus kinase inhibitor. Clin Cosmet Investig Dermatol. 2024;17:529\u201337.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"1","key":"1059_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13256-024-04366-w","volume":"18","author":"S Dierckx","year":"2024","unstructured":"Dierckx S, Nisolle J, Boutsen Y. Dramatic response of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome to tofacitinib monotherapy: a case report. J Med Case Rep. 2024;18(1):57.","journal-title":"J Med Case Rep"},{"issue":"2","key":"1059_CR18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1056\/NEJMra1202117","volume":"368","author":"JJ O'Shea","year":"2013","unstructured":"O\u2019Shea JJ, Holland SM, Staudt LM. JAKs and STATs in immunity, immunodeficiency, and cancer. N Engl J Med. 2013;368(2):161\u201370.","journal-title":"N Engl J Med"},{"issue":"5","key":"1059_CR19","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.cell.2012.09.044","volume":"151","author":"G Vahedi","year":"2012","unstructured":"Vahedi G, Takahashi H, Nakayamada S, Sun HW, Sartorelli V, Kanno Y, et al. STATs shape the active enhancer landscape of T cell populations. Cell. 2012;151(5):981\u201393.","journal-title":"Cell"},{"issue":"2","key":"1059_CR20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0950-3579(94)80022-7","volume":"8","author":"MF Kahn","year":"1994","unstructured":"Kahn MF, Khan MA. The Sapho syndrome. Baillieres Clin Rheumatol. 1994;8(2):333\u201362.","journal-title":"Baillieres Clin Rheumatol"},{"issue":"15","key":"1059_CR21","first-page":"1635","volume":"54","author":"G Hayem","year":"2004","unstructured":"Hayem G. Sapho syndrome. Rev Prat. 2004;54(15):1635\u20136.","journal-title":"Rev Prat"},{"key":"1059_CR22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nrendo.2009.58","volume":"5","author":"J Marini","year":"2009","unstructured":"Marini J. Bone use of bisphosphonates in children-proceed with caution. Nat Rev Endocrinol. 2009;5:241\u20133.","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"1059_CR23","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1189\/jlb.0513250","volume":"95","author":"Y Mizoguchi","year":"2014","unstructured":"Mizoguchi Y, Tsumura M, Okada S, Hirata O, Minegishi S, Imai K, et al. Simple diagnosis of STAT1 gain-of-function alleles in patients with chronic mucocutaneous candidiasis. J Leukoc Biol. 2014;95(4):667\u201376.","journal-title":"J Leukoc Biol"},{"issue":"10","key":"1059_CR24","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.3899\/jrheum.2022-1323","volume":"50","author":"E Wu","year":"2023","unstructured":"Wu E, Oliver M, Scheck J, Lapidus S, Akca U, Yasin S, et al. Feasibility of conducting comparative effectiveness research and validation of a clinical disease activity score for chronic nonbacterial osteomyelitis. J Rheumatol. 2023;50(10):1333\u201340.","journal-title":"J Rheumatol"},{"issue":"5","key":"1059_CR25","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1080\/14397595.2019.1660027","volume":"30","author":"T Miyamae","year":"2020","unstructured":"Miyamae T, Tani Y, Kishi T, Yamanaka H, Singh G. Updated version of Japanese Childhood Health Assessment Questionnaire (CHAQ). Mod Rheumatol. 2020;30(5):905\u20139.","journal-title":"Mod Rheumatol"},{"issue":"1","key":"1059_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0304-3959(83)90088-X","volume":"16","author":"AM Carlsson","year":"1983","unstructured":"Carlsson AM. Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain. 1983;16(1):87\u2013101.","journal-title":"Pain"},{"issue":"2","key":"1059_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1297\/cpe.25.71","volume":"25","author":"T Isojima","year":"2016","unstructured":"Isojima T, Kato N, Ito Y, Kanzaki S, Murata M. Growth standard charts for Japanese children with mean and standard deviation (SD) values based on the year 2000 national survey. Clin Pediatr Endocrinol. 2016;25(2):71\u20136.","journal-title":"Clin Pediatr Endocrinol"},{"issue":"7","key":"1059_CR28","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/rheumatology\/key058","volume":"57","author":"H Girschick","year":"2018","unstructured":"Girschick H, Finetti M, Orlando F, Schalm S, Insalaco A, Ganser G, et al. The multifaceted presentation of chronic recurrent multifocal osteomyelitis: a series of 486 cases from the Eurofever international registry. Rheumatology. 2018;57(7):1203\u201311.","journal-title":"Rheumatology"},{"issue":"10","key":"1059_CR29","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1093\/rheumatology\/keh295","volume":"43","author":"C Kerrison","year":"2004","unstructured":"Kerrison C, Davidson JE, Cleary AG, Beresford MW. Pamidronate in the treatment of childhood SAPHO syndrome. Rheumatology. 2004;43(10):1246\u201351.","journal-title":"Rheumatology"},{"issue":"6","key":"1059_CR30","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s11914-017-0405-9","volume":"15","author":"SR Hofmann","year":"2017","unstructured":"Hofmann SR, Kapplusch F, Girschick HJ, Morbach H, Pablik J, Ferguson PJ, et al. Chronic Recurrent Multifocal Osteomyelitis (CRMO): presentation, pathogenesis, and treatment. Curr Osteoporos Rep. 2017;15(6):542\u201354.","journal-title":"Curr Osteoporos Rep"},{"key":"1059_CR31","doi-asserted-by":"publisher","first-page":"1169659","DOI":"10.3389\/fped.2023.1169659","volume":"11","author":"R Hetrick","year":"2023","unstructured":"Hetrick R, Oliver M. Pediatric autoinflammatory bone disorders-a mini review with special focus on pathogenesis and inborn errors of immunity. Front Pediatr. 2023;11:1169659.","journal-title":"Front Pediatr"},{"issue":"9","key":"1059_CR32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11926-020-00928-1","volume":"22","author":"CM Hedrich","year":"2020","unstructured":"Hedrich CM, Morbach H, Reiser C, Girschick HJ. New insights into adult and paediatric Chronic Non-bacterial Osteomyelitis CNO. Curr Rheumatol Rep. 2020;22(9):52.","journal-title":"Curr Rheumatol Rep"},{"issue":"5","key":"1059_CR33","first-page":"6605","volume":"17","author":"G Luo","year":"2018","unstructured":"Luo G, Li FF, Li XM, Wang ZG, Zhang B. TNF-\u03b1 and RANKL promote osteoclastogenesis by upregulating RANK via the NF-\u03baB pathway. Mol Med Rep. 2018;17(5):6605\u201311.","journal-title":"Mol Med Rep"},{"issue":"11","key":"1059_CR34","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1210\/endo.141.11.7739","volume":"141","author":"L Gilbert","year":"2000","unstructured":"Gilbert L, He XF, Farmer P, Boden S, Kozlowski M, Rubin J, et al. Inhibition of osteoblast differentiation by tumor necrosis factor-\u03b1. Endocrinology. 2000;141(11):3956\u201364.","journal-title":"Endocrinology"},{"issue":"1","key":"1059_CR35","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/rheumatology\/kel190","volume":"46","author":"A Jansson","year":"2007","unstructured":"Jansson A, Renner ED, Ramser J, Mayer A, Haban M, Meindl A, et al. Classification of non-bacterial osteitis: retrospective study of clinical, immunological and genetic aspects in 89 patients. Rheumatology (Oxford). 2007;46(1):154\u201360.","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"1059_CR36","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1093\/rheumatology\/ken185","volume":"47","author":"M Hurtado-Nedelec","year":"2008","unstructured":"Hurtado-Nedelec M, Chollet-Martin S, Nicaise-Roland P, Grootenboer-Mignot S, Ruimy R, Meyer O, et al. Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome. Rheumatology (Oxford). 2008;47(8):1160\u20137.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"1059_CR37","first-page":"120","volume":"27","author":"GM Alenius","year":"2009","unstructured":"Alenius GM, Eriksson C, Rantap\u00e4\u00e4 DS. Interleukin-6 and soluble interleukin-2 receptor alpha-markers of inflammation in patients with psoriatic arthritis? Clin Exp Rheumatol. 2009;27(1):120\u20133.","journal-title":"Clin Exp Rheumatol"},{"key":"1059_CR38","doi-asserted-by":"publisher","first-page":"785705","DOI":"10.1155\/2015\/785705","volume":"2015","author":"H Przepiera-B\u0119dzak","year":"2015","unstructured":"Przepiera-B\u0119dzak H, Fischer K, Brzosko M. Serum IL-6 and IL-23 levels and their correlation with angiogenic cytokines and disease activity in ankylosing spondylitis, psoriatic arthritis, and SAPHO Syndrome. Mediators Inflamm. 2015;2015:785705.","journal-title":"Mediators Inflamm"},{"issue":"2","key":"1059_CR39","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.4049\/jimmunol.177.2.1282","volume":"177","author":"X Zhang","year":"2006","unstructured":"Zhang X, Edwards JP, Mosser DM. Dynamic and transient remodeling of the macrophage IL-10 promoter during transcription. J Immunol. 2006;177(2):1282\u20138.","journal-title":"J Immunol"},{"key":"1059_CR40","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1546-0096-12-30","volume":"12","author":"R Scianaro","year":"2014","unstructured":"Scianaro R, Insalaco A, Laudiero L, De Vito R, Pezzullo M, Teti A, et al. Deregulation of the IL-1\u03b2 axis in chronic recurrent multifocal osteomyelitis. Pediatr Rheumatol Online J. 2014;12:30.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"6812","key":"1059_CR41","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/35046102","volume":"408","author":"H Takayanagi","year":"2000","unstructured":"Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K, et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-\u03b3. Nature. 2000;408(6812):600\u20135.","journal-title":"Nature"},{"issue":"10","key":"1059_CR42","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.3324\/haematol.2013.083741","volume":"98","author":"O Hirata","year":"2013","unstructured":"Hirata O, Okada S, Tsumura M, Kagawa R, Miki M, Kawaguchi H, et al. Heterozygosity for the Y701C <i>STAT1<\/i> mutation in a multiplex kindred with multifocal osteomyelitis. Haematologica. 2013;98(10):1641\u20139.","journal-title":"Haematologica"},{"issue":"3","key":"1059_CR43","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00247-012-2544-6","volume":"43","author":"C Falip","year":"2013","unstructured":"Falip C, Alison M, Boutry N, Job-Deslandre C, Cotten A, Azoulay R, et al. Chronic recurrent multifocal osteomyelitis (CRMO): a longitudinal case series review. Pediatr Radiol. 2013;43(3):355\u201375.","journal-title":"Pediatr Radiol"},{"issue":"1","key":"1059_CR44","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1546-0096-11-47","volume":"11","author":"CM Hedrich","year":"2013","unstructured":"Hedrich CM, Hofmann SR, Pablik J, Morbach H, Girschick HJ. Autoinflammatory bone disorders with special focus on chronic recurrent multifocal osteomyelitis (CRMO). Pediatr Rheumatol Online J. 2013;11(1):47.","journal-title":"Pediatr Rheumatol Online J"},{"key":"1059_CR45","doi-asserted-by":"publisher","first-page":"204062232211291","DOI":"10.1177\/20406223221129163","volume":"13","author":"H Zhao","year":"2022","unstructured":"Zhao H, Ding Y, Yang J, Luo Y, Xu Z, Miao J. Efficacy and safety of bisphosphonates on childhood osteoporosis secondary to chronic illness or its treatment: a meta-analysis. Ther Adv Chronic Dis. 2022;13:20406223221129164.","journal-title":"Ther Adv Chronic Dis"},{"issue":"7","key":"1059_CR46","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.jaip.2023.03.011","volume":"11","author":"S Butala","year":"2023","unstructured":"Butala S, Castelo-Soccio L, Seshadri R, Simpson EL, O\u2019Shea JJ, Bieber T, et al. Biologic versus small molecule therapy for treating moderate to severe atopic dermatitis: clinical considerations. J Allergy Clin Immunol Pract. 2023;11(7):1361\u201373.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"7","key":"1059_CR47","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1002\/eji.202048922","volume":"51","author":"FR Spinelli","year":"2021","unstructured":"Spinelli FR, Meylan F, O\u2019Shea JJ, Gadina M. JAK inhibitors: Ten years after. Eur J Immunol. 2021;51(7):1615\u201327.","journal-title":"Eur J Immunol"},{"issue":"7","key":"1059_CR48","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1136\/annrheumdis-2020-219012","volume":"80","author":"PG Traves","year":"2021","unstructured":"Traves PG, Murray B, Campigotto F, Galien R, Meng A, Di Paolo JA. JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib. Ann Rheum Dis. 2021;80(7):865\u201375.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1059_CR49","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3343\/alm.2018.38.6.503","volume":"38","author":"EH Nah","year":"2018","unstructured":"Nah EH, Kim S, Cho S, Cho HI. Complete blood count reference intervals and patterns of changes across pediatric, adult, and geriatric ages in Korea. Ann Lab Med. 2018;38(6):503\u201311.","journal-title":"Ann Lab Med"},{"issue":"5","key":"1059_CR50","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1373\/clinchem.2011.177741","volume":"58","author":"DA Colantonio","year":"2012","unstructured":"Colantonio DA, Kyriakopoulou L, Chan MK, Daly CH, Brinc D, Venner AA, et al. Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children. Clin Chem. 2012;58(5):854\u201368.","journal-title":"Clin Chem"},{"issue":"1","key":"1059_CR51","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/archdischild-2013-305349","volume":"100","author":"ES Ramsay","year":"2015","unstructured":"Ramsay ES, Lerman MA. How to use the erythrocyte sedimentation rate in paediatrics. Arch Dis Child Educ Pract Ed. 2015;100(1):30\u20136.","journal-title":"Arch Dis Child Educ Pract Ed"},{"issue":"1","key":"1059_CR52","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/cyto.a.22520","volume":"87","author":"F Tosato","year":"2015","unstructured":"Tosato F, Bucciol G, Pantano G, Putti MC, Sanzari MC, Basso G, et al. Lymphocytes subsets reference values in childhood. Cytometry A. 2015;87(1):81\u20135.","journal-title":"Cytometry A"},{"issue":"4","key":"1059_CR53","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/j.1365-3083.2012.02671.x","volume":"75","author":"EJH Schatorj\u00e9","year":"2012","unstructured":"Schatorj\u00e9 EJH, Gemen EFA, Driessen GJA, Leuvenink J, van Hout RWNM, de Vries E. Paediatric reference values for the peripheral T cell compartment. Scand J Immunol. 2012;75(4):436\u201344.","journal-title":"Scand J Immunol"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-025-01059-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-025-01059-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-025-01059-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T13:36:38Z","timestamp":1737639398000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-025-01059-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,23]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1059"],"URL":"https:\/\/doi.org\/10.1186\/s12969-025-01059-6","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,23]]},"assertion":[{"value":"6 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research protocols were approved by Kyushu University Hospital Ethics Committee and informed written consent was obtained from a subject or a parent or guardian, participating in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from a subject or a parent or guardian for the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}